Literature DB >> 8174965

Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy.

D M Scott-Coombes1, S A Whawell, M N Vipond, L Crnojevic, J N Thompson.   

Abstract

Coagulopathy is a well recognised complication of peritoneovenous shunting for ascites. The relative contributions of primary fibrinolysis and disseminated intravascular coagulation remain controversial. Plasminogen activating activity was significantly lower in malignant ascites (n = 10, median < 0.02 (range < 0.02-1.26) IU/ml) than in alcoholic ascites (n = 10, 1.07 (0.30-1.49) IU/ml) (p < 0.05). Fibrinolytic activity was determined by a balance between tissue plasminogen activator and plasminogen activator inhibitor-1. There was no significant difference between the two groups in the concentration of tissue plasminogen activator (34 (12-64) ng/ml in malignant ascites v 29 (12-43) ng/ml in alcoholic ascites), but the concentration of plasminogen activator inhibitor-1 was significantly higher in malignant ascites (736 (213-1651) ng/ml) than in alcohol ascites (29 (12-43) ng/ml) (p < 0.05). Malignant ascites contained significantly higher concentrations of urokinase (0.7 (< 0.1-1.3) ng/ml v 0.2 (< 0.1-0.6) ng/ml in alcoholic ascites) and plasminogen activator inhibitor-2 (33 (< 6-140) ng/ml v 9 (< 6-28) ng/ml alcoholic ascites). The plasminogen activating activity of alcohol ascites may lead to primary fibrinolysis after peritoneovenous shunting. The considerably lower activity found in malignant ascites may explain why coagulopathy after shunting is less pronounced in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174965      PMCID: PMC1374366          DOI: 10.1136/gut.34.8.1120

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients.

Authors:  V G Lévy; P Opolon; N Pauleau; J Caroli
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

2.  Relationship between fibrinolysis of cultured cells and malignancy.

Authors:  W E Laug; P A Jones; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

3.  Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen.

Authors:  J M Henderson; S F Stein; M Kutner; M B Wiles; J D Ansley; D Rudman
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

4.  Ascites-induced LeVeen shunt coagulopathy.

Authors:  M V Ragni; J H Lewis; J A Spero
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

5.  Peritoneovenous shunting for cirrhotic versus malignant ascites.

Authors:  K M Kostroff; D W Ross; J M Davis
Journal:  Surg Gynecol Obstet       Date:  1985-09

6.  Ethyl alcohol enhances plasminogen activator secretion by endothelial cells.

Authors:  W E Laug
Journal:  JAMA       Date:  1983-08-12       Impact factor: 56.272

7.  Complications after peritoneovenous shunting for ascites.

Authors:  P D Greig; B Langer; L M Blendis; B R Taylor; M F Glynn
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

8.  Peritoneovenous shunting in the management of malignant ascites.

Authors:  A K Straus; D L Roseman; T M Shapiro
Journal:  Arch Surg       Date:  1979-04

9.  Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid.

Authors:  K Huber; J Wojta; J C Kirchheimer; D Ermler; B R Binder
Journal:  Eur J Clin Invest       Date:  1988-12       Impact factor: 4.686

10.  Management of malignant ascites with peritoneovenous shunting.

Authors:  R B Reinhold; J J Lokich; J Tomashefski; P Costello
Journal:  Am J Surg       Date:  1983-04       Impact factor: 2.565

View more
  6 in total

1.  Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure.

Authors:  Ta-Wei Hsu; Yi-Chuan Chen; Meei-Ju Wu; Anna Fen-Yau Li; Wu-Chang Yang; Yee-Yung Ng
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-02-02

2.  Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.

Authors:  A Zoia; M Drigo; C J Piek; P Simioni; M Caldin
Journal:  J Vet Intern Med       Date:  2016-11-16       Impact factor: 3.333

3.  Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.

Authors:  Andrea Zoia; Michele Drigo; Christine J Piek; Paolo Simioni; Marco Caldin
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

4.  Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.

Authors:  Andrea Zoia; Michele Drigo; Christine J Piek; Helena Calcini; Marco Caldin; Paolo Simioni
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

5.  Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.

Authors:  Johannes Thaler; Ton Lisman; Peter Quehenberger; Lena Hell; Philipp Schwabl; Bernhard Scheiner; Theresa Bucsics; Rienk Nieuwland; Cihan Ay; Michael Trauner; Ingrid Pabinger; Thomas Reiberger; Mattias Mandorfer
Journal:  Thromb Haemost       Date:  2021-07-04       Impact factor: 6.681

Review 6.  Fibrinolysis in Dogs with Intracavitary Effusion: A Review.

Authors:  Andrea Zoia; Michele Drigo; Marco Caldin; Paolo Simioni; Christine J Piek
Journal:  Animals (Basel)       Date:  2022-09-20       Impact factor: 3.231

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.